Class IIITerminated in FDA datasetRecall initiated Jul 13, 2020

BTREX PLUS, Dietary Supplement 100 Caplets

Recalling firm: Lopez Gonzalez Santana Corporation

Why it was recalled

CGMP Deviations: Presence of damaged tablets

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Oct 8, 2021.

Check your package

Compare the exact product and package details with the label you have.

ProductBTREX PLUS, Dietary Supplement 100 Caplets

FDA code information

Lot # 33491, Exp. 12/22

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

BTREX PLUS, Dietary Supplement 100 Caplets

Extracted codes and context

TypeCode / valueContext
lot33491Lot # 33491, Exp. 12/22

Original FDA recall reason

CGMP Deviations: Presence of damaged tablets

Recall details

Recall number
F-0541-2021
Event ID
87759
FDA status
Terminated
Initiated
Jul 13, 2020
Reported
May 26, 2021
Classified
May 19, 2021
Terminated
Oct 8, 2021
Quantity
662 bottles.
Location
Rio Piedras, PR, United States
Initiation type
Voluntary: Firm initiated
Notification
E-Mail

Where it was distributed

Domestic distribution only-PR

FDA source record · F-0541-2021

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.